• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Eastern Mediterranean Health Journal: Al-Magallat al-Sihhiyyat li-Sarq al-Mutawassit >A country-wide comparison of cost recovery and financing systems of blood and blood products
【24h】

A country-wide comparison of cost recovery and financing systems of blood and blood products

机译：全国范围内血液和血液制品的成本回收和融资系统比较

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background : As blood is a scarce and expensive resource, irrational blood usage places huge burden on health expenditures. In response to this challenge, governments and health care providers are developing different strategies to optimize blood utilization. Among these strategies is trying to raise the public awareness on the actual costs of the blood production and changing the cost recovery systems of blood and blood components. Aims : This study aims to compare cost recovery and financing systems of blood and blood products in different countries. Methods : This research was an email-based survey of 30 countries from four HDI categories. All related literature was reviewed. Results : Out of 28 countries, 19 have blood and blood products that are provided totally free of charge to the patients. In nine countries blood and blood products are totally or partially chargeable to the patients. Conclusions : In countries with low and lower-middle income economies, total or partial costs of blood and blood products are recovered directly from the patients. While countries in which blood and blood products are ‘free of charge’ for patients are mostly categorized in upper-middle- or high-income economies with well-developed healthcare and insurance systems. There is no clear relation between blood usage and the type of cost recovery system. However, having an efficient cost recovery system will help blood establishments to sustain their service delivery.
机译：背景：由于血液是一种稀缺且昂贵的资源，不合理使用血液给卫生支出带来了沉重负担。为了应对这一挑战，政府和医疗保健提供者正在制定不同的策略来优化血液利用。在这些策略中，试图提高公众对血液生产实际成本的认识，并改变血液和血液成分的成本回收系统。目的：本研究旨在比较不同国家血液和血液制品的成本回收和融资系统。方法：本研究是对来自四个HDI类别的30个国家/地区进行电子邮件调查。所有相关文献进行了审查。结果：在28个国家中，有19个国家为患者免费提供血液和血液制品。在九个国家，血液和血液制品应全部或部分向患者收费。结论：在低收入和中低收入国家，血液和血液制品的全部或部分费用可直接从患者那里收回。虽然为患者提供“免费”血液和血液制品的国家/地区大多归类于拥有发达医疗保健和保险系统的中上或高收入经济体。血液使用与成本回收系统的类型之间没有明确的关系。但是，拥有一个高效的成本回收系统将有助于血液企业维持其服务水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号